This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Liaw PC (2004) Endogenous protein C activation in patients with severe sepsis. Crit Care Med 32:S214–S218
Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Fisher CJ Jr (2001) Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344:699–709
Richard J-C, Bregeon F, Leray V, Le Bars D, Costes N, Tourvieille C, Lavenne F, Devouassoux-Shisheboran M, Gimenez G, Guerin C (2007) Effect of activated protein C on pulmonary blood flow and cytokine production in experimental acute lung injury. Intensive Care Med DOI 10.1007/s00134-007-0782-0
Schuster DP (1994) ARDS: clinical lessons from the oleic acid model of acute lung injury. Am J Respir Crit Care Med 149:245–260
Rosenthal C, Caronia C, Quinn C, Lugo N, Sagy M (1998) A comparison among animal models of acute lung injury. Crit Care Med 26:912–916
Hill LL, Chen DL, Kozlowski J, Schuster DP (2004) Neutrophils and neutrophil products do not mediate pulmonary hemodynamic effects of endotoxin on oleic acid-induced lung injury. Anesth Analg 98:452–457
Gust R, Kozlowski J, Stephenson AH, Schuster DP (1998) Synergistic hemodynamic effects of low-dose endotoxin and acute lung injury. Am J Respir Crit Care Med 157:1919–1926
Chen DL, Schuster DP (2004) Positron emission tomography with [18F]fluorodeoxyglucose to evaluate neutrophil kinetics during acute lung injury. Am J Physiol Lung Cell Mol Physiol 286:L834–840
Jian MY, Koizumi T, Tsushima K, Fujimoto K, Kubo K (2005) Activated protein C attenuates acid-aspiration lung injury in rats. Pulm Pharmacol Ther 18:291–296
Murakami K, Okajima K, Uchiba M, Johno M, Nakagaki T, Okabe H, Takatsuki K (1996) Activated protein C attenuates endotoxin-induced pulmonary vascular injury by inhibiting activated leukocytes in rats. Blood 87:642–647
Murakami K, Okajima K, Uchiba M, Johno M, Nakagaki T, Okabe H, Takatsuki K (1997) Activated protein C prevents LPS-induced pulmonary vascular injury by inhibiting cytokine production. Am J Physiol 272:L197–202
Sturn DH, Kaneider NC, Feistritzer C, Djanani A, Fukudome K, Wiedermann CJ (2003) Expression and function of the endothelial protein C receptor in human neutrophils. Blood 102:1499–1505
Nick JA, Coldren CD, Geraci MW, Poch KR, Fouty BW, O'Brien J, Gruber M, Zarini S, Murphy RC, Kuhn K, Richter D, Kast KR, Abraham E (2004) Recombinant human activated protein C reduces human endotoxin-induced pulmonary inflammation via inhibition of neutrophil chemotaxis. Blood 104:3878–3885
Maybauer MO, Maybauer DM, Fraser JF, Traber LD, Westphal M, Enkhbaatar P, Cox RA, Huda R, Hawkins HK, Morita N, Murakami K, Mizutani A, Herndon DN, Traber DL (2006) Recombinant human activated protein C improves pulmonary function in ovine acute lung injury resulting from smoke inhalation and sepsis. Crit Care Med 34:2432–2438
Robriquet L, Collet F, Tournoys A, Prangere T, Neviere R, Fourrier F, Guery BP (2006) Intravenous administration of activated protein C in Pseudomonas-induced lung injury: impact on lung fluid balance and the inflammatory response. Respir Res 7:41
Tomashefski JF Jr (2000) Pulmonary pathology of acute respiratory distress syndrome. Clin Chest Med 21:435–466
Gunther A, Mosavi P, Heinemann S, Ruppert C, Muth H, Markart P, Grimminger F, Walmrath D, Temmesfeld-Wollbruck B, Seeger W (2000) Alveolar fibrin formation caused by enhanced procoagulant and depressed fibrinolytic capacities in severe pneumonia. Comparison with the acute respiratory distress syndrome. Am J Respir Crit Care Med 161:454–462
Traber DL, Herndon DN, Enkhbaatar P, Maybauer MO, Maybauer DM (2007) The pathophysiology of inhalation injury. In: Herndon DN (ed.) Total burn care. Saunders, London, pp. 248–261
Eichacker PQ, Natanson C, Danner RL (2006) Surviving sepsis – practice guidelines, marketing campaigns, and Eli Lilly. N Engl J Med 355:1640–1642
No author has a conflict of interest that relates to the content discussed in this manuscript.
This editorial refers to the article available at: http://dx.doi.org/10.1007/s00134-007-0782-0.
About this article
Cite this article
Velik-Salchner, C., Wenzel, V., Maybauer, D.M. et al. Recombinant human activated protein C in experimental models of acute lung injury: the timing is critical!. Intensive Care Med 33, 2048–2050 (2007). https://doi.org/10.1007/s00134-007-0783-z